KIM-1 as a Blood-Based Marker for Early Detection of Kidney Cancer: A Prospective Nested Case-Control Study.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Scelo, GhislaineMuller, David C
Riboli, Elio
Johansson, Mattias
Cross, Amanda J
Vineis, Paolo
Tsilidis, Konstantinos K
Brennan, Paul
Boeing, Heiner
Peeters, Petra H M
Vermeulen, Roel C H
Overvad, Kim
Bueno-de-Mesquita, H Bas
Severi, Gianluca
Perduca, Vittorio
Kvaskoff, Marina
Trichopoulou, Antonia
la Vecchia, Carlo
Karakatsani, Anna
Palli, Domenico
Sieri, Sabina
Panico, Salvatore
Weiderpass, Elisabete
Sandanger, Torkjel M
Nøst, Therese H
Agudo, Antonio
Quirós, J Ramón
Rodríguez-Barranco, Miguel
Chirlaque, Maria-Dolores
Key, Timothy J
Khanna, Prateek
Bonventre, Joseph V
Sabbisetti, Venkata S
Bhatt, Rupal S
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
KIM-1 as a Blood-Based Marker for Early Detection of Kidney Cancer: A Prospective Nested Case-Control Study.Published in
Clin Cancer Res 2018; 24(22):5594-5601PMID
30037816ae974a485f413a2113503eed53cd6c53
10.1158/1078-0432.CCR-18-1496
Scopus Count
Collections
Related articles
- Diagnostic role of kidney injury molecule-1 in renal cell carcinoma.
- Authors: Zhang KJ, Wilson GD, Kara S, Majeske A, Zhang PL, Hafron JM
- Issue date: 2019 Nov
- Kidney Injury Molecule-1 (KIM-1) in Blood Plasma of Patients with Clear-Cell Carcinoma.
- Authors: Kushlinskii NE, Gershtein ES, Naberezhnov DS, Taipov MA, Bezhanova SD, Pushkar' DY, Matveev VB, Stilidi IS
- Issue date: 2019 Jul
- Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma.
- Authors: Gatto F, Blum KA, Hosseini SS, Ghanaat M, Kashan M, Maccari F, Galeotti F, Hsieh JJ, Volpi N, Hakimi AA, Nielsen J
- Issue date: 2018 Oct
- Vitamin D binding protein and risk of renal cell carcinoma in the prostate, lung, colorectal and ovarian cancer screening trial.
- Authors: Kratzer TB, Weinstein SJ, Albanes D, Mondul AM
- Issue date: 2020 Aug 1
- Circulating biomarkers of one-carbon metabolism in relation to renal cell carcinoma incidence and survival.
- Authors: Johansson M, Fanidi A, Muller DC, Bassett JK, Midttun Ø, Vollset SE, Travis RC, Palli D, Mattiello A, Sieri S, Trichopoulou A, Lagiou P, Trichopoulos D, Ljungberg B, Hallmans G, Weiderpass E, Skeie G, González CA, Dorronsoro M, Peeters PH, Bueno-de-Mesquita HB, Ros MM, Boutron Ruault MC, Fagherazzi G, Clavel F, Sánchez MJ, Gurrea AB, Navarro C, Quiros JR, Overvad K, Tjønneland A, Aleksandrova K, Vineis P, Gunter MJ, Kaaks R, Giles G, Relton C, Riboli E, Boeing H, Ueland PM, Severi G, Brennan P
- Issue date: 2014 Dec